chrX-47915116-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_007137.5(ZNF81):āc.470A>Gā(p.Asn157Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00732 in 1,204,219 control chromosomes in the GnomAD database, including 28 homozygotes. There are 2,890 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_007137.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF81 | NM_007137.5 | c.470A>G | p.Asn157Ser | missense_variant | 5/5 | ENST00000338637.13 | NP_009068.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF81 | ENST00000338637.13 | c.470A>G | p.Asn157Ser | missense_variant | 5/5 | 3 | NM_007137.5 | ENSP00000341151 | P1 | |
ZNF81 | ENST00000376954.6 | c.470A>G | p.Asn157Ser | missense_variant | 6/6 | 5 | ENSP00000366153 | P1 | ||
ZNF81 | ENST00000376950.4 | c.277+19176A>G | intron_variant | 5 | ENSP00000366149 |
Frequencies
GnomAD3 genomes AF: 0.00518 AC: 578AN: 111558Hom.: 2 Cov.: 22 AF XY: 0.00468 AC XY: 158AN XY: 33732
GnomAD3 exomes AF: 0.00492 AC: 852AN: 173163Hom.: 2 AF XY: 0.00515 AC XY: 311AN XY: 60347
GnomAD4 exome AF: 0.00754 AC: 8234AN: 1092611Hom.: 26 Cov.: 30 AF XY: 0.00762 AC XY: 2733AN XY: 358811
GnomAD4 genome AF: 0.00516 AC: 576AN: 111608Hom.: 2 Cov.: 22 AF XY: 0.00465 AC XY: 157AN XY: 33792
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:4
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Aug 31, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2016 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 19, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at